Journal of Cancer Therapy

Volume 8, Issue 9 (September 2017)

ISSN Print: 2151-1934   ISSN Online: 2151-1942

Google-based Impact Factor: 0.30  Citations  h5-index & Ranking

In Vitro Evaluation of Anticancer Drugs with Kinetic and Static Alternating Cell Culture System

HTML  XML Download Download as PDF (Size: 490KB)  PP. 845-859  
DOI: 10.4236/jct.2017.89074    1,036 Downloads   2,009 Views  Citations

ABSTRACT

Variable bioreactors have been developed for the evaluation of anti-cancer drug efficacy. The Kinetic and Static Alternating Cell Culture System (KSACCS) combines the advantages of kinetic bioreactors and static cultures to improve cell growth by providing adequate metabolic support while minimizing shear-stress. In the current studies, the KSACCS in the ZYX Bioreactor could significantly increase the sensitivity of lung cancer cells (PLS008) and leukemia cells (HL60) to anticancer drugs Cisplatin and 5-FU by accelerating the apoptosis of cancer cells. It was also shown that excessive agitation of the cells could lead to severe cell damage, which resulted in a diminished sensitivity of anticancer drug evaluation, and co-culture systems tend to reduce the sensitivity of anticancer drug evaluation although it might better mimic in vivo conditions.

Share and Cite:

Zhang, Y. , Wang, Y. , Wang, Z. , Farhangfar, F. and Zimmerman, M. (2017) In Vitro Evaluation of Anticancer Drugs with Kinetic and Static Alternating Cell Culture System. Journal of Cancer Therapy, 8, 845-859. doi: 10.4236/jct.2017.89074.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.